A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
Saved in:
| Title: | A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer. |
|---|---|
| Authors: | Werner TL; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Ray A; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Lamb JG; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., VanBrocklin M; Department of Surgery, University of Utah, Salt Lake City, UT., Hueftle K; Department of Medicine, University of Utah, Salt Lake City, UT., Cohen AL; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Beck AC; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Buys SS; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Dyess DL; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL., Butler TW; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL., Dumlao TL; Banner M.D. Anderson Cancer Center, Gilbert, AZ., Neumayer L; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of Arizona, Tucson, AZ., Khong HT; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL; Department of Breast Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address: hung.khong@moffitt.org. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2017 Nov; Vol. 17 (7), pp. 503-509. Date of Electronic Publication: 2017 Apr 29. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
